Pharmafile Logo
Pharmafocus logo
Advanced Search

GSK’s Arzerra conditionally approved in Europe

April 20, 2010
Research and Development, Sales and Marketing Arzerra, GSK, leukaemia

GlaxoSmithKline’s orphan cancer treatment Arzerra has been given conditional marketing authorisation in the European Union. Arzerra (ofatumumab) can be used …

News

Oracle buys eClinical specialist Phase Forward for $685m

April 20, 2010
Research and Development Covance, Oracle, Phase Forward

Business software giant Oracle has taken a leap forward in the healthcare arena with a $685 million cash offer to …

News

Emerging markets and generics poised to drive pharma growth

April 20, 2010
Sales and Marketing IMS, em, emerging markets

The global pharma market will reach $1.1 trillion in 2014 through growth primarily driven by emerging markets and generics, according …

News

Lilly faces substantial costs from US health reform

April 20, 2010
Sales and Marketing 2010 financials, Obama, lilly

Lilly expects to lose up to $485 million this year as a direct result of the US healthcare reforms, but …

News

ABPI appoints Roche’s Paul Catchpole

April 20, 2010
Sales and Marketing ABPI, UK, appointment, sales and marketing

UK industry association the ABPI has appointed Paul Catchpole as director of value and access. He will join the association …

Appointment

Third Apotex plant cited in FDA warning letter

April 19, 2010
Manufacturing and Production Apotex, generics, manufacturing compliance

Canada’s Apotex has been sent a warning letter citing manufacturing violations at a facility in Toronto that are identical to …

News

Trial boost for Merck KGaA’s cladribine

April 19, 2010
Research and Development Cladribine, MS, Merck KGaA, Merck Serono

New data from German pharma company Merck suggests its oral multiple sclerosis treatment cladribine has been successful in treating relapsing …

News

Novartis set to boost generic portfolio

April 19, 2010
Sales and Marketing Novartis, Sandoz, generics

Novartis’ generics arm Sandoz has signed a deal to acquire US-based inhalable drug specialist Oriel Therapeutics. Sandoz will gain rights …

News

MedImmune: building a biologics future

April 19, 2010
Research and Development MedImmune, biologics

I paid my visit to MedImmune’s UK headquarters in Cambridge only days after its parent company AstraZeneca announced the closure …

Feature

Action Pharma appoints new chief executive

April 19, 2010
Research and Development Action Pharma, appointment, research and development

Ingelise Saunders has joined Danish biotech Action Pharma as its new chief executive. She will be involved in seeking partners …

Appointment

Lane Earl Cox wins allergy blood test account

April 16, 2010
Medical Communications LEC, Phadia, allergy

Healthcare advertising agency Lane Earl & Cox has won the account to promote an allergy blood test product from diagnostics …

News

Genzyme appoint investor to outmanoeuvre Icahn

April 16, 2010
Sales and Marketing Contamination, Genzyme

Genzyme has appointed the head of one of its biggest shareholders to its board in order to block a hostile …

News

Pharma manufacturing news in brief

April 16, 2010
Manufacturing and Production

A round-up of news in the pharmaceutical manufacturing arena includes the removal of CFC-based MDIs from the US market, facility …

News
Roche's China operations

Emerging markets lift Roche in Q1

April 16, 2010
Sales and Marketing Roche, emerging markets

Roche saw its sales grow 9% overall in the first quarter, with emerging markets medicines revenues showing a healthy 38% …

News

Maike Fieber joins Photosound

April 16, 2010
Medical Communications Photosound, appointment, medical communications

Photosound has appointed Maike Fieber as an account manager.She joins the agency from Ogilvy & Mather in Dusseldorf, where she …

Appointment

Cephalon completes acquisition of generics firm Mepha

April 16, 2010
Sales and Marketing Cephalon, generics

Specialist pharmaceutical company Cephalon has completed the $615.4 million acquisition of Mepha. Based in Switzerland, Mepha specialises in using reformulation …

News
Blog footer

Digital Pharma: Online ‘keepy uppies’ from Bayer

April 15, 2010
Medical Communications Bayer Schering Pharma, Langland, digi game, digital pharma, disease awareness campaigns, haemophilia, iphone

Bayer Schering Pharma is counting down to World Haemophilia Day with a football-themed online disease awareness campaign. The centre-piece of …

News

Lixisenatide scores in phase III trial

April 15, 2010
Research and Development GLP-1, Lixisenatide, diabetes

Sanofi-Aventis’ novel, once-daily diabetes treatment lixisenatide has successfully met its phase III glucose blood level and glycaemic control endpoints. The …

News

Healthcare key to voting preferences

April 15, 2010
NHS, election

Healthcare is a key factor when deciding which political candidate to support for more than half of UK voters, according …

News

Hikma expands in Middle East & North Africa

April 15, 2010
Manufacturing and Production, Sales and Marketing Hikma, em

UK-headquartered Hikma Pharmaceuticals has signed a flurry of deals that expand its position in the fast-growing Middle East and North …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025